Harwood Feffer LLP Announces Investigation of NantHealth, Inc.
Mar 9, 2017
NEW YORK, March 9, 2017 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of NantHealth, Inc. ("NantHealth" or the "Company") (NASDAQ: NH) concerning whether the board has breached its fiduciary duties to shareholders.
On March 6, 2017, STATnews.com published an article titled "How the world's richest doctor gave away millions – then steered the cash back to his company," reporting that NantHealth's founder Patrick Soon-Shiong ("Dr. Soon") gave $12 million to the University of Utah that required the University to spend $10 million genetic sequencing work performed by NantHealth. According to the article, this arrangement enabled NantHealth to inflate by more than 50% the number of test orders that it reported to investors in 2016.
Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.
If you own NantHealth shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Robert I. Harwood, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
Email: [email protected]
Follow us on Twitter: @HarwoodFeffer
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.
The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
SOURCE Harwood Feffer LLP